The growth of Viagra and its influence on the drug landscape presents a complex question for investors. While the early sales figures were remarkable, the intellectual property has expired, leading to a deluge of copycat alternatives that are reducing revenue. Moreover, the sector is facing challenges related to demographic trends and shifting h… Read More